ロード中...
Desmoteplase for Acute Ischemic Stroke within 3 to 9 Hours after Symptom Onset: Evidence from Randomized Controlled Trials
Recent studies have shown inconsistent results regarding the value of desmoteplase for treating acute ischemic stroke (AIS) when administered within an extended time window. We performed a meta-analysis to explore the value of desmoteplase in AIS treatment. The MEDLINE, EMBASE, and Cochrane Library...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5037417/ https://ncbi.nlm.nih.gov/pubmed/27671010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep33989 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|